| 标题 |
Efficacy of once-weekly tirzepatide versus once-daily insulin degludec on glycaemic control measured by continuous glucose monitoring in adults with type 2 diabetes (SURPASS-3 CGM): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Diabetes & Endocrinology 作者:Tadej Battelino; Richard M. Bergenstal; Ángel Rodríguez; Laura Fernández Landó; Ross Bray; et al 出版日期:2022-04-22 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)